» Articles » PMID: 23494459

The Use of Mass Spectrometry to Improve the Diagnosis and the Management of the HPA Axis

Overview
Publisher Springer
Specialty Endocrinology
Date 2013 Mar 16
PMID 23494459
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Liquid chromatography coupled to tandem mass spectrometry (LC-MS/MS) is becoming a standard analytical tool in the clinical laboratory for the measurement of small molecules, including steroid hormones. Endocrinologists are coming to acknowledge the superior quality of measurement that is achievable by LC-MS/MS through the enhanced analytical specificity and high sensitivity that this technique offers over conventional immunoassay (IA) methodologies. Additionally, LC-MS/MS overcomes many of the problems encountered in immunoassays, such as anti-reagent antibody interferences and cross-reactivity with structurally related compounds. The potential benefits of applying LC-MS/MS for the assessment of the hypothalamic-pituitary-adrenal (HPA) axis are beginning to be realised. This review critically evaluates recent developments in the application of LC-MS/MS for measurement of glucocorticoids and mineralocorticoids towards the diagnosis and management of HPA axis disorders and aims to address the current unmet need in this expanding field of endocrinology for which future studies into the potential applications of LC-MS/MS should be directed.

Citing Articles

Case Report: Severe McCune-Albright syndrome presenting with neonatal Cushing syndrome: navigating through clinical obstacles.

Unsal Y, Gozmen O, User I, Hizarcioglu H, Gulhan B, Ekinci S Front Endocrinol (Lausanne). 2023; 14:1209189.

PMID: 37560302 PMC: 10407558. DOI: 10.3389/fendo.2023.1209189.


Pitfalls in the Diagnosis and Management of Hypercortisolism (Cushing Syndrome) in Humans; A Review of the Laboratory Medicine Perspective.

Flowers K, Shipman K Diagnostics (Basel). 2023; 13(8).

PMID: 37189516 PMC: 10137494. DOI: 10.3390/diagnostics13081415.


ACTH Stimulation Test for the Diagnosis of Secondary Adrenal Insufficiency: Light and Shadow.

Birtolo M, Antonini S, Saladino A, Zampetti B, Lavezzi E, Chiodini I Biomedicines. 2023; 11(3).

PMID: 36979883 PMC: 10045406. DOI: 10.3390/biomedicines11030904.


Performance characteristics of the light-initiated chemiluminescent assay for quantitative determination of progesterone.

Chen K, Wu D, Gao M, Yan Y, Li H Ann Transl Med. 2021; 9(18):1411.

PMID: 34733963 PMC: 8506739. DOI: 10.21037/atm-21-3119.


Management of hypopituitarism: a perspective from the Brazilian Society of Endocrinology and Metabolism.

Garmes H, Boguszewski C, Miranda P, Martins M, da Silva S, Abucham Filho J Arch Endocrinol Metab. 2021; 65(2):212-230.

PMID: 33905631 PMC: 10065316. DOI: 10.20945/2359-3997000000335.


References
1.
Alexandraki K, Kaltsas G, le Roux C, Fassnacht M, Ajodha S, Christ-Crain M . Assessment of serum-free cortisol levels in patients with adrenocortical carcinoma treated with mitotane: a pilot study. Clin Endocrinol (Oxf). 2009; 72(3):305-11. DOI: 10.1111/j.1365-2265.2009.03631.x. View

2.
Raff H, Raff J, Findling J . Late-night salivary cortisol as a screening test for Cushing's syndrome. J Clin Endocrinol Metab. 1998; 83(8):2681-6. DOI: 10.1210/jcem.83.8.4936. View

3.
VAN SETERS A, MOOLENAAR A . Mitotane increases the blood levels of hormone-binding proteins. Acta Endocrinol (Copenh). 1991; 124(5):526-33. DOI: 10.1530/acta.0.1240526. View

4.
Jones R, Owen L, Adaway J, Keevil B . Simultaneous analysis of cortisol and cortisone in saliva using XLC-MS/MS for fully automated online solid phase extraction. J Chromatogr B Analyt Technol Biomed Life Sci. 2011; 881-882:42-8. DOI: 10.1016/j.jchromb.2011.11.036. View

5.
Mendel C . The free hormone hypothesis. Distinction from the free hormone transport hypothesis. J Androl. 1992; 13(2):107-16. View